ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselNuclidium AG
Nuclidium AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Nuclidium AG is a biotechnology company developing copper-based radiopharmaceuticals for cancer diagnosis and treatment. Its programmes pair copper-61 for diagnostic imaging with copper-67 for targeted therapy.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Nuclidium AG

✓ Offered4
Radiopharmaceutical oncology pipeline
Development of copper-based therapeutics and companion diagnostics for precision oncology, including clinical programmes against prostate cancer, metastatic breast cancer and neuroendocrine tumours.
Copper-based radiotheranostics platform (CuTrace™)
Proprietary platform for diagnostic and therapeutic copper-based radiopharmaceuticals with Cu-61 and Cu-67 radionuclides, targeted molecules and improved production and distribution.
Production and supply chain for radiopharmaceuticals
Set-up and operation of a production and supply network for copper-based radiopharmaceuticals with scalable manufacturing, reliable supply and distribution in Europe and North America.
Copper User’s Group
Network for isotope producers, clinicians, researchers and industry partners to exchange data, coordinate supply and promote the clinical use of Cu radiotheranostics.
Trust & reputation

ranQ Trust Score of Nuclidium AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of November 2026

Without public customer reviews the score stays capped.

Nuclidium AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Nuclidium AG scores 83.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.79.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Nuclidium AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Nuclidium AG scores 55.2 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.77.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.33.34%
Qualifications+0.00

Nuclidium AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

May 29, 2026Media
NUCLIDIUM's Series B reaches CHF 105 million with latest extension
startupticker.ch
July 10, 2025Media
CHF 79 million to advance Nuclidium’s copper-based radiopharmaceutical platform
startupticker.ch

Knowledge

No knowledge articles yet

Once Nuclidium AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Nuclidium AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Nuclidium AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Nuclidium AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bäumleingasse 18
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-412.395.606
Founded
2018 · 8 years
Last commercial register change
June 11, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    LS
    Lantheus Switzerland GmbH
    Basel
    CP
    Corden Pharma International Switzerland GmbH
    Basel
    EP
    Eumedica Pharmaceuticals AG
    Basel
    SP
    SFL Pharma GmbH
    Basel
    BM
    BeOne Medicines International GmbH
    Basel
    CT
    CORETAG Therapeutics AG
    Basel
    YA
    Ymmunobio AG
    Riehen
    TP
    Torpedo Pharmaceuticals AG
    Basel